Affordable Access

deepdyve-link
Publisher Website

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.

Authors
  • Arachchillage, D R J
  • Efthymiou, M
  • Mackie, I J
  • Lawrie, A S
  • Machin, S J
  • Cohen, H
Type
Published Article
Journal
Thrombosis Research
Publisher
Elsevier
Publication Date
Feb 01, 2015
Volume
135
Issue
2
Pages
388–393
Identifiers
DOI: 10.1016/j.thromres.2014.11.037
PMID: 25555316
Source
Medline
Keywords
License
Unknown

Abstract

In conclusion, both rivaroxaban and warfarin provided effective anticoagulation, as assessed by inhibition of TG and makers of in-vivo coagulation activation.

Report this publication

Statistics

Seen <100 times